Europe — EMA
Zirabev (Bevacizumab)
Zirabev (bevacizumab) is an intravenous therapy for certain cancers, designed to slow tumor growth by targeting blood vessel formation. This overview covers its
Request sourcing
What is Bevacizumab?
Zirabev (bevacizumab) is an intravenous therapy for certain cancers, designed to slow tumor growth by targeting blood vessel formation. This overview covers its uses, effects, and safety considerations for patients and caregivers.
What is Bevacizumab used for?
Zirabev is used to treat various cancers by interfering with the blood supply tumors need to grow. It is commonly prescribed for colorectal, lung, kidney, cervical, and ovarian cancers in combination with other therapies. Patients often ask, 'what is bevacizumab used for' when discussing treatment options with healthcare providers.
What are the side effects of Bevacizumab?
Zirabev works by binding to a protein that helps new blood vessels form, which may slow or stop the growth of cancerous tissue. Patients may notice changes in energy levels or appetite during treatment. It does not cure cancer but is intended to manage disease progression.
What precautions apply to Bevacizumab?
Zirabev is administered under medical supervision due to potential risks like bleeding or wound healing issues. Patients should inform their doctor about any upcoming surgeries or existing conditions. Regular monitoring is typically required during treatment.
What does Bevacizumab interact with?
Zirabev may interact with other medications that affect blood clotting or blood pressure. Combining it with certain chemotherapy drugs or vascular endothelial growth factor (VEGF) inhibitors could alter effects. Alcohol use and herbal supplements should be discussed with a healthcare provider.
